Tech Company Inital Public Offerings
Xencor IPO
Xencor was acquired by . Shares became public on 12/3/2013.
Transaction Overview
Company Name
Announced On
12/3/2013
Transaction Type
IPO
Amount
$69,850,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
111 West Lemon Ave.
Monrovia, CA 91016
USA
Monrovia, CA 91016
USA
Phone
Website
Email Address
Overview
In collaboration with our partners -- including leading biotechnology company Genentech and pharmaceutical company Eli Lilly -- we are selectively designing next-generation protein drug candidates with improved selectivity, efficacy and safety.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bassil Dahiyat
Chief Medical Officer
Paul Foster
VP - Finance
John Kuch
VP - R & D
John Desjarlais
Browse more venture capital transactions:
Prev: 12/3/2013: SoluLink venture capital transaction
Next: 12/3/2013: DataSift venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs